Zeel is a tech platform dedicated to connecting skilled healthcare practitioners to clients and patients across the United States. With a focus on best-in-class pain relief, medical testing, and musculoskeletal care, Zeel offers services both in person and virtually, ensuring vital health and wellness treatments are seamless and accessible to everyone. The company's mission to innovate the way patients and clients access trusted in-person and tele-healthcare underscores its leadership role in the industry. Founded in 2010, Zeel operates within the Health Care, Internet, and Mobile sectors, leveraging technology to bridge the gap between practitioners and those in need of care. In January 17, 2023, Zeel received a convertible note investment from FJ Labs, a testament to its promising potential and disruptive approach to healthcare delivery. The provision of mobile apps for both iOS and Android platforms underscores Zeel’s commitment to leveraging technology to expand the reach of its services, underlining the company's dedication to pioneering new solutions in the healthcare industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Convertible Note | Unknown | 1 | 17 Jan 2023 | |
Series B | Unknown | 2 | 19 Apr 2019 | |
Series B | Unknown | 1 | 01 Apr 2018 | |
Series B | $11.25M | 1 | Palisades Growth | 25 Jan 2018 |
Series A | $10.00M | 9 | Spafinder Wellness, Partech +2 | 24 Mar 2016 |
No recent news or press coverage available for Zeel.